Schizophrenia: all 3,539 studies

Page 12 of 36. Open to participants first (473), then studies with results posted, then the rest; newest registration first within each.

• A Double-blind, Placebo-controlled Study of the Safety and Efficacy of Paliperidone Extended Release (ER) in the Treatment of Schizophrenia in Adolescent PatientsCompletedNCT00518323Phase 3Results posted
• Treatment of Negative Symptoms of Schizophrenia With Transcranial Magnetic Stimulation (TMS)TerminatedNCT00517075Phase 2Results posted
• Glucose and Lipid Metabolism on Antipsychotic MedicationCompletedNCT00515723Not applicableResults posted
• Illness Management and Recovery for Veterans With Severe Mental IllnessCompletedNCT00515671Not applicableResults posted
• Systematic Evaluation of Antiviral Medication in SchizophreniaCompletedNCT00514449Phase 2Results posted
• Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With OlanzapineCompletedNCT00512070Not applicableResults posted
• Use of Galantamine and CDP-choline (Citicoline) to Treat Adults With SchizophreniaCompletedNCT00509067Phase 2Results posted
• A Phase 4 Study to Assess the Effects of Aripiprazole Versus Other Atypical Antipsychotics in the Treatment of Schizophrenic Patients With Metabolic SyndromeTerminatedNCT00508157Phase 4Results posted
• Oxytocin Add on Study for Stable Schizophrenic PatientsTerminatedNCT00506909Not applicableResults posted
• MK0249 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0249-016)CompletedNCT00506077Phase 2Results posted
• A Multicenter Study of NAP (AL-108) in SchizophreniaCompletedNCT00505765Phase 2Results posted
• Treatment Study for Cognitive Deficits in SchizophreniaCompletedNCT00505076Phase 2Results posted
• Predictors of Treatment Outcome for Smokers With and Without SchizophreniaCompletedNCT00501007Results posted
• Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-UsualCompletedNCT00498550Phase 4Results posted
• Varenicline Adjunctive Treatment in SchizophreniaCompletedNCT00492349Phase 4Results posted
• Rasagiline in the Treatment of Persistent Negative Symptoms of SchizophreniaCompletedNCT00492336Phase 4Results posted
• Open-label Study of Flexible-dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia.CompletedNCT00488319Phase 3Results posted
• Efficacy and Safety of Armodafinil as Adjunctive Therapy in Schizophrenic Adults With Cognitive DeficitsCompletedNCT00487942Phase 2Results posted
• An Open Label Multicentre Study to Determine the Dose Distribution of Paliperidone ER in Patients With SchizophreniaCompletedNCT00473434Phase 3Results posted
• Improving Basic and Social Cognition in Veterans With SchizophreniaCompletedNCT00470106Not applicableResults posted
• The Effectiveness of FMPO in Improving the Quality of Care for Persons With Severe Mental Illness.CompletedNCT00466323Not applicableResults posted
• Metabolic Signatures and Biomarkers in SchizophreniaCompletedNCT00466310Phase 1Results posted
• Treatment With Acamprosate in Patients With Schizophrenia and Comorbid AlcoholismCompletedNCT00463346Phase 3Results posted
• Efficacy and Tolerability of Switching to Ziprasidone From Other AntipsychoticsCompletedNCT00458211Phase 4Results posted
• Effects of Weekly Dosing of D-cycloserine on Cognitive Function in Individuals With SchizophreniaCompletedNCT00455702Phase 4Results posted
• Cognitive Adaptive Training for Improving Medication Adherence, Symptoms, and Function in People With SchizophreniaCompletedNCT00455663Not applicableResults posted
• Study of the Effects of Mecamylamine and Varenicline in SchizophreniaCompletedNCT00455650Not applicableResults posted
• An Observational Study On Metabolic Syndrome Parameters In Schizophrenia Patients Treated With Atypical AntipsychoticsCompletedNCT00448630Results posted
• Diabetes in Neuropsychiatric DisordersCompletedNCT00446992Phase 1/2Results posted
• Staccato Loxapine Single Dose PKCompletedNCT00444028Phase 1Results posted
• Effectiveness of Tropisetron Plus Risperidone for Improving Cognitive and Perceptual Disturbances in SchizophreniaCompletedNCT00435370Phase 3Results posted
• Modafinil for Treatment of Cognitive Dysfunction in SchizophreniaCompletedNCT00423943Phase 4Results posted
• Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective DisorderCompletedNCT00423878Phase 4Results posted
• Improving Adherence to Oral Antipsychotic Medications in People With SchizophreniaCompletedNCT00406718Not applicableResults posted
• Study Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To ZiprasidoneCompletedNCT00406315Phase 4Results posted
• High-Dose Oral Ziprasidone Versus Conventional Dosing in Participants With Residual Schizophrenia SymptomsCompletedNCT00403546Phase 3Results posted
• Assessment of Safety and Efficacy of Therapy for the Prevention of Weight Gain Associated With OlanzapineCompletedNCT00401973Phase 3Results posted
• A Study to Evaluate Effectiveness and Safety of ER OROS Paliperidone in Patients With SchizophreniaCompletedNCT00396565Phase 3Results posted
• Improving Medication Adherence Among People With Schizophrenia Through the Use of 2-way PagersCompletedNCT00392236Not applicableResults posted
• Study of Aripiprazole in Patients With Schizophrenia- Effects on Glucose Metabolism-CompletedNCT00392197Phase 4Results posted
• The Effects of Nicotine on Cognition in SchizophreniaCompletedNCT00383747Phase 4Results posted
• Efficacy of Pimozide Augmentation for Clozapine Partial ResponseCompletedNCT00374244Phase 2Results posted
• Effects of Armodafinil on Cognition for Patients With Schizophrenia or Schizoaffective DisorderCompletedNCT00373672Phase 4Results posted
• Staccato Loxapine in Agitation (Proof of Concept)CompletedNCT00369577Phase 2Results posted
• A Definitive Estrogen Patch Study (ADEPT)CompletedNCT00357006Phase 2Results posted
• A Placebo-Controlled, Cross-Over Trial of AripiprazoleCompletedNCT00351936Phase 4Results posted
• Ziprasidone for Clozapine- or Olanzapine-Associated Diabetes MellitusCompletedNCT00351000Phase 4Results posted
• Clinical Trial of Dipyridamole in SchizophreniaCompletedNCT00349973Not applicableResults posted
• Effectiveness of Aripiprazole for Improving Side Effects of Clozapine in the Treatment of People With SchizophreniaCompletedNCT00345033Phase 4Results posted
• Ziprasidone for Improving Insulin Sensitivity in People With Schizophrenia Who Are at Risk for DiabetesCompletedNCT00338949Phase 4Results posted
• Facilitation of NMDA Receptor Function in Patients With Schizophrenia and Co-morbid AlcoholismCompletedNCT00338598Phase 2Results posted
• Efficacy Study of Early Onset of Antipsychotic Drug Action in SchizophreniaCompletedNCT00337662Phase 4Results posted
• Rosiglitazone for Clozapine Induced Glucose Metabolism ImpairmentCompletedNCT00337350Phase 4Results posted
• Predictors of Response to Cognitive Remediation in SchizophreniaCompletedNCT00333970Not applicableResults posted
• Psychosocial Therapy and Risperidone Treatment in Work Performance in Recent-Onset SchizophreniaCompletedNCT00333177Phase 4Results posted
• Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating EfficacyCompletedNCT00330863Phase 4Results posted
• Oral Versus Injectable Risperidone for Treating First-Episode SchizophreniaCompletedNCT00330551Phase 4Results posted
• Safety and Effectiveness of D-serine in SchizophreniaCompletedNCT00322023Phase 2Results posted
• Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode PsychosisCompletedNCT00320671Phase 4Results posted
• Olanzapine Pamoate Depot Versus Oral Olanzapine on Treatment Outcomes in Outpatients With SchizophreniaCompletedNCT00320489Phase 3Results posted
• Effectiveness of the Screen, Test, Immunize, Reduce Risk, and Refer (STIRR) Intervention for People With Both a Mental and Substance Abuse DisorderCompletedNCT00316303Phase 2Results posted
• Optimizing Response in Psychosis StudyTerminatedNCT00314327Phase 4Results posted
• Specialized Treatment Early in Psychosis (STEP)CompletedNCT00309452Not applicableResults posted
• Transcranial Magnetic Stimulation for "Voices"CompletedNCT00308997Phase 2Results posted
• Does The Addition Of Divalproex Sodium ER To An Atypical Antipsychotic Drug (APD) Improve Cognition And Psychopathology In Outpatients With Schizophrenia (SCH) Or Schizoaffective Disorder (SAD)?CompletedNCT00306475Phase 4Results posted
• Comparing the Effect of Under the Tongue Olanzapine Versus Swallowed Olanzapine on Body Mass Index (A Ratio of Weight to Height)CompletedNCT00303602Phase 4Results posted
• Evaluation of Effectiveness of Risperdal® Consta® Compared to Abilify® Over a Two-year Period in Patients With SchizophreniaCompletedNCT00299702Phase 4Results posted
• Glycine vs Placebo for the Schizophrenia ProdromeCompletedNCT00291226Phase 2/3Results posted
• Anticonvulsant Mood Stabilizers, Antipsychotic Drugs and the Insulin Resistance SyndromeCompletedNCT00288366Not applicableResults posted
• Estimating and Reducing the Cardiovascular Risk of Patients With Schizophrenia Drugs From Lipid Measures and Ischemic Electrocardiographic ChangesTerminatedNCT00288353Phase 3Results posted
• The Use of Skills Training to Augment Compensated Work Therapy (CWT)/VI for Veterans With SMICompletedNCT00272168Not applicableResults posted
• An Efficacy and Safety Study of Long-Term Risperidone Microspheres in Participants With SchizophreniaCompletedNCT00269919Phase 4Results posted
• Safety And Tolerability Of Ziprasidone In Adolescents With SchizophreniaTerminatedNCT00265382Phase 3Results posted
• 6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptom Patients Who Completed the Protocol 25543 (25544)(P05777)CompletedNCT00265343Phase 3Results posted
• Motivational Interviewing to Improve Work Outcomes in SchizophreniaCompletedNCT00261716Phase 3Results posted
• Safety And Efficacy Of Ziprasidone In Adolescents With SchizophreniaTerminatedNCT00257192Phase 3Results posted
• A Study of Risperidone Long-Acting Injection Versus Oral Antipsychotics in Schizophrenia Participants With a History of Being Poorly Compliant With Taking Their MedicationTerminatedNCT00256997Phase 4Results posted
• Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute SchizophreniaCompletedNCT00254202Phase 3Results posted
• Folate Supplementation in SchizophreniaCompletedNCT00249288Phase 4Results posted
• Cognitive Rehabilitation in SchizophreniaCompletedNCT00248794Not applicableResults posted
• A Trial Comparing Risperidone Long-Acting Injection With Oral Antipsychotic in the Treatment of Early PsychosisCompletedNCT00246259Phase 4Results posted
• Aripiprazole for Schizophrenia Outpatients Completing BMS Clinical TrialsCompletedNCT00239356Phase 3Results posted
• D-Serine Treatment of Negative Symptoms and Cognitive Deficits in SchizophreniaCompletedNCT00237809Phase 3Results posted
• Functional Rehabilitation of Older Patients With SchizophreniaCompletedNCT00237796Not applicableResults posted
• Pioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With SchizophreniaCompletedNCT00231894Phase 4Results posted
• Quetiapine Fumarate (SEROQUEL) in the Treatment of Adolescent Patients With Schizophrenia and Bipolar I DisorderCompletedNCT00227305Phase 3Results posted
• Neurocognitive Effects of Ziprasidone: Relationship to Working Memory and Dopamine BlockadeCompletedNCT00225498Not applicableResults posted
• Long-acting Injectable Risperidone in Patients With Schizophrenia After an Acute EpisodeCompletedNCT00216671Phase 4Results posted
• A Study of Relapse Prevention and the Effectiveness of Long-acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective DisorderCompletedNCT00216476Phase 3Results posted
• The Effects of Aripiprazole on the Processing of Rewards in SchizophreniaTerminatedNCT00209027Not applicableResults posted
• A Study of the Cataractogenic Potential of Seroquel and Risperdal in the Treatment of Participants With Schizophrenia or Schizoaffective DisorderCompletedNCT00206102Phase 4Results posted
• Changes in Adiposity, Metabolic Measures From Atypicals to AripiprazoleCompletedNCT00205660Phase 4Results posted
• Valproate in Late Life SchizophreniaCompletedNCT00194025Phase 4Results posted
• Safety Study of Olanzapine and a Comparator in Patients With Schizophrenia and Schizoaffective DisorderCompletedNCT00190749Phase 4Results posted
• Supported Employment and Skills Training in Conjunction With Pharmacotherapy in Schizophrenia PatientsCompletedNCT00183625Phase 4Results posted
• Treatment of Mania Symptoms With Drug TherapyCompletedNCT00183443Phase 3Results posted
• Atomoxetine for Treatment of Weight Gain in Olanzapine or Clozapine PatientsCompletedNCT00176436Phase 4Results posted
• Efficacy Study of Galantamine for Cognitive Impairments in SchizophreniaCompletedNCT00176423Phase 4Results posted
• Extension Study of Patients Successfully Treated by Ziprasidone in Study A1281031CompletedNCT00174447Phase 3Results posted
• 6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptoms Patients Who Completed the First 6- Month Trial (A7501014)(COMPLETED)(P05772)CompletedNCT00174265Phase 3Results posted

← Schizophrenia overview